Company Profile
Bio-Reference Laboratories Stock Price, News & Analysis
- Ticker:
- BRLI
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
4.70 USD
Close
Last updated: December 22, 2023 at 00:00
—
Market cap
Why the stock is moving
BRLI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Bio-Reference Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Bio-Reference Laboratories is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Business Model Characteristics
Bio-Reference Laboratories is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.
Position Within the Biotechnology Landscape
Compared with therapeutic biotech names, Bio-Reference Laboratories sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bio-Reference Laboratories (BRLI)?
Bio-Reference Laboratories (BRLI) most recently closed at 4.70 USD.
What does Bio-Reference Laboratories do?
Bio-Reference Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
On which exchange is BRLI stock listed?
Bio-Reference Laboratories (BRLI) is associated with NASDAQ, United States, Biotechnology.
What is Bio-Reference?
Bio-Reference Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Which conditions is Bio-Reference Laboratories targeting with Bio-Reference?
Bio-Reference Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
What is Laboratories?
Bio-Reference Laboratories is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.